(Q51979170)

19 April 2018

title

Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes (English)

1 reference

19 April 2018

Mycobacterium tuberculosis

main subject

0 references

author

Julie A. McMurry

1

1 reference

19 April 2018

Anne Searls De Groot

6

1 reference

19 April 2018

author name string

Sbai H

2

1 reference

19 April 2018

Gennaro ML

3

1 reference

19 April 2018

Carter EJ

4

1 reference

19 April 2018

Martin W

5

1 reference

19 April 2018

publication date

25 December 2004

1 reference

19 April 2018

published in

Tuberculosis

1 reference

19 April 2018

volume

85

1 reference

19 April 2018

issue

1-2

1 reference

19 April 2018

page(s)

95-105

1 reference

19 April 2018

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Tuberculosis control in the 21st century

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Variation in protection by BCG: implications of and for heterologous immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

New tuberculosis vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

7 January 2021

Tuberculosis vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

How can immunology contribute to the control of tuberculosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

ESAT-6 subunit vaccination against Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Epidemiology of tuberculosis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Evaluation of Human Antimycobacterial Immunity Using Recombinant Reporter Mycobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

38 000 MW antigen-specific major histocompatibility complex class I restricted interferon-gamma-secreting CD8+ T cells in healthy contacts of tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Immuno-informatics: Mining genomes for vaccine components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Use of T cell epitopes for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

From genome to vaccine: in silico predictions, ex vivo verification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

The PROSITE database, its status in 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

A comparison of signal sequence prediction methods using a test set of signal peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Development of new vaccines and diagnostic reagents against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Strategy for isolating and sequencing biologically derived MHC class I peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

Tuberculosis and leprosy: attempts to identify T-cell antigens of potential value for vaccine design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

7 January 2021

Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

7 January 2021

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

7 January 2021

T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2004.09.005

7 January 2021

10.1016/J.TUBE.2004.09.005

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018